

@article {3913,
	title = {Evaluation of RIX4414, a live, attenuated rotavirus vaccine, in a randomized, double-blind, placebo-controlled phase 2 trial involving 2464 Singaporean infants.},
	journal = {The Journal of Infectious Diseases},
	volume = {192 Suppl},
	year = {2005},
	pages = {S6{\textendash}SS16},
	abstract = {<p>At present, no rotavirus vaccine is commercially available for use worldwide. Hence, a live, attenuated monovalent vaccine was developed with human strain \{\{\}RIX4414\{\}\} \{\{\}(G1P1A\{\}\} P[8] specificity). Vaccination trials involving infants are ongoing in developed and developing countries.</p>
},
	doi = {10.1086/431511},
	url = {http://dx.doi.org/10.1086/431511},
	author = {Phua, Kong B and Quak, Seng H and Lee, Bee W and Emmanuel, Shanta C and Goh, Paul and Han, Htay H and De Vos, B{\'e}atrice and Bock, Hans L}
}
